[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"7fe47d5ad6e86684f3ced7d9789be9c58bc35e2cb72b91580b05483245717ae4","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"eb285635c569ad32b50b8a74167cc9cd9a77c2da94d5ad2325cd92b4278d43a0","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Provide historical context for the modern drug discovery and development process.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Describe the high-level goals and activities that take place during discovery, preclinical development, and clinical development and the different functional areas that perform this work.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Apply the knowledge learned throughout the course to address specific drug development scenarios.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Propose novel strategies to address current drug development challenges.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Evaluate scientific literature and regulatory documents to find important information about specific drugs.\"}]"},{"run_id":"legacy-03b0bbb9723907cf3d1b41cf0bb34837dc398e42","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"fc98ddcc4e15c2a5af2e736dc8cc224f1efad4eef57ab64841591607a769bb31","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0837245627eb714ae6bb0375f7abe8f41042011f","semester":"1262","observed_at":"2025-04-16 05:20:33.104844+00:00","record_version_id":"fc98ddcc4e15c2a5af2e736dc8cc224f1efad4eef57ab64841591607a769bb31","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-08c92e359bbbc110b0778b7e0b15d6f40000e6b1","semester":"1262","observed_at":"2025-08-21 07:05:14.730696+00:00","record_version_id":"32986b3ad1b2e51d2fccd9027729caf87f0fff6d8f5523b117e6d485d2ed3372","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0944d76440dc778fbb89626058c10451009ce9c6","semester":"1262","observed_at":"2025-05-21 03:36:18.194118+00:00","record_version_id":"3c0bad69093141ef0940f6813d79486dc4ada6123b1dbe67420ae3adf8f17932","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0a7f4bce29c816ef4d3d71b4eb8a2a3e15e33cc1","semester":"1262","observed_at":"2025-06-18 20:04:02.695444+00:00","record_version_id":"f88e8c86cd41c166f4a2a446d66816de1578b5ab0807e3c6e1c6c57d4b8b3778","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0ab917f827a7de22ebdc1087114d377a31c4687b","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"4285038e7879559f75b39893f9ab4b43e32717586a81218de395af4fe6ebe1b8","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0c40ecab4b6db9333d1f18aef816e3ee659e300c","semester":"1262","observed_at":"2025-05-25 18:02:34.797617+00:00","record_version_id":"4cad5f2fd11927df8ea53e26d1b33c3076e5b888dd3cdbdc271307c22c9eb2d6","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-0cb4d29a588ec7f11c7e00b7cf5dc3a0d23d0349","semester":"1266","observed_at":"2026-01-22 01:00:26.555427+00:00","record_version_id":"ce3225d2fea4d58e86e21f1956a03036433ad54e397780f6d92a24827a7f7bfe","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-11c30ec39e91498cbfcf3a923c53a4b03e387280","semester":"1262","observed_at":"2025-07-20 04:58:26.847117+00:00","record_version_id":"9d3f3aad034f8329ee9dac7941f0c8cc9bd51d5541804f145b9f87bc5cd9151c","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-13cd500edf2587e9a3428f326253738fbea965ea","semester":"1264","observed_at":"2025-12-14 04:50:04.653658+00:00","record_version_id":"64844a531f1aa44fbc38c81b632e1b8d3a21c4326313deddcb72581e9b4e7489","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-1da08b2de39f05e6bc877c189fc2fd6eeda563f5","semester":"1262","observed_at":"2025-07-01 00:03:56.707251+00:00","record_version_id":"2d94f9adc7cdf4408bf22800802de64fe4a75dd59b05b116172063f8b07fe9b4","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2031af47efe133b0e7877f433286ff07385afc41","semester":"1262","observed_at":"2025-07-02 20:16:45.749584+00:00","record_version_id":"65f4a8069cd9424d83ff5869e1b44980deaa89eebd6a42a6c7b83403b390e396","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-238eba6f32fbc30407f616dd0628ff02a2a824dd","semester":"1262","observed_at":"2025-08-17 05:15:07.788352+00:00","record_version_id":"871b0eeafc655b7ee8c70395d6c054ec291432f17e356c97c4f54ea6da94fc44","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-25f0ff56bc4d80f8a8afa1a0bcce8dae6fddb5e5","semester":"1262","observed_at":"2025-05-25 17:20:25.942090+00:00","record_version_id":"f0c8ffd70ab0f41d6fe4bb836948df9df60d4d9beadea6ddfd7da4b398f15a65","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2923f91826ce253b7aeefa9f75b4a39fe4c80ff0","semester":"1262","observed_at":"2025-08-10 05:10:25.938416+00:00","record_version_id":"c9d98ce1c040e6c7a98d88484bf37c161095a66d55978c575b67b53c569af4ac","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2a05214a4023e0157fa6f7d188c85308f714176c","semester":"1262","observed_at":"2025-09-07 04:56:38.255315+00:00","record_version_id":"deda70736501eaa961739db5d77acca895b39f43e1168e85b79f22f93906d553","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-2b1b8e39131de92b94620b25c5bbb25690efed4c","semester":"1262","observed_at":"2025-06-01 07:54:53.913454+00:00","record_version_id":"022c5c4e7ee48ffb6a4e4d613969d2670c29d632fba20ae02a860bb48676552d","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-33a1225644e5a5855d60f66e65413946e72fedf4","semester":"1262","observed_at":"2025-06-22 01:52:05.152650+00:00","record_version_id":"27aef65a92d8d41b72ef667c72de79d7e6103dbb708e333c983bd7755248cb15","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3b89c83dbf5208e13756184de1f2b2d0c09af35f","semester":"1262","observed_at":"2025-06-30 06:40:10.235522+00:00","record_version_id":"7bdd99c0365b797c1550a6d24d770e062871a6367c02e595ddb7647e74e1a4fc","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3c3eebf7f35c39364b445a2fa5a112ce28dbb4a1","semester":"1262","observed_at":"2025-06-01 17:03:59.062985+00:00","record_version_id":"053a6f69e2e03256828888f99abad449ceb52434600fe4a51b5508171b534b30","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-3fa4dd71391f1c9cf4ab2216680bbc428689f92d","semester":"1262","observed_at":"2025-05-25 01:15:58.180530+00:00","record_version_id":"3109b7eeb21d0d802471c06582078c28e5ce59807510afd1b24fdd70a781a9ac","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-4040aa216da722a34483f68fc1e129ea571ae08d","semester":"1262","observed_at":"2025-06-01 07:27:39.695506+00:00","record_version_id":"91afb6c66a3dd1e647907c796ee15729ed07e9a5d433e8ec37c72cb8b9bc05d4","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-454d53cd690294459f8ad0793cc3ed562060e56c","semester":"1262","observed_at":"2025-05-25 01:34:00.536004+00:00","record_version_id":"7984f2d0ce167989673af22a8ed655b2be8892cc0e5ca2ebdb3aa465631a7953","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-486f091e051fdb4ccdb80ee7b4fb0a5814510324","semester":"1264","observed_at":"2025-11-16 05:32:31.273726+00:00","record_version_id":"5575f3c1b35d720e89f4e1f97966211f06029d1d2baae0a186b5a7c8e92bff69","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50393cfc5fd5598d4f4731ef1919f2ff53af07d9","semester":"1262","observed_at":"2025-06-30 06:05:57.438846+00:00","record_version_id":"2cf6b1fa0adeaf7d36ee958757547ad2d6e6498ff7d628dc852bb228200fccc2","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-50f6947786b208c800db8bbd0cec84a8f0f187d2","semester":"1262","observed_at":"2025-06-02 03:49:42.915428+00:00","record_version_id":"f2d350fd06e80f034366436633879bf11c4fd80eda6a4e555ba777de300cb7a2","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-51d86ed4082dced3803c295419b0ec8440942016","semester":"1264","observed_at":"2025-11-12 04:50:41.141307+00:00","record_version_id":"4f0a80ac959f219179d0ea7858190e7411d6cf6b2904a62d6b21263327565da3","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-53101bd1c10db0d00d094e4c9154d4c244ff23d9","semester":"1262","observed_at":"2025-10-05 04:58:05.366968+00:00","record_version_id":"e6eae448c7d08b3182a4c0f1828a5b8d969ce56e41252011cf125cfc9a7e7a2a","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-58751151c564e11c5cb8aedd3a2d3527c22f73eb","semester":"1262","observed_at":"2025-06-01 06:59:01.536576+00:00","record_version_id":"f01c090ab94b1e66a48679bb48509dc414350c94e87f027d26e2f23fcd5aaaae","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5c4c8d3701a333ba4ddadef7d0b5dde8440fcdf0","semester":"1262","observed_at":"2025-06-01 01:57:51.256704+00:00","record_version_id":"8e40ad3924c6e381c444c7b7dde89cbefb418900213c3188c1e1fa1506a5c4fe","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5d20d9f81651d3c83fcaa2fd10870ce6e5d5a685","semester":"1262","observed_at":"2025-05-21 16:48:48.484741+00:00","record_version_id":"ffd9a7ceea1d8c6b36376480fb1c215a4f11be18aa88bf5169b813cb8686f746","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-5feaebf2ab37051c86ad360cc0fa0d7e0e2ea295","semester":"1262","observed_at":"2025-05-24 15:58:23.378859+00:00","record_version_id":"2124cd3046696ad039b314ca333352a80d5c470a07d8a219b513208d6d9909f2","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-60949965544fce098cc006354e201149005fb77b","semester":"1264","observed_at":"2025-10-26 05:07:14.077864+00:00","record_version_id":"a33119af121463e6eb16fa955af19c8c8a92fbcfef6f26870d0fdf0f4a5f2287","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-639225ac3addf8522f1d30cb4fe26054ea7f8c49","semester":"1262","observed_at":"2025-06-01 08:14:42.497608+00:00","record_version_id":"0cb503c5ca1cd112077a17ab2cfaf06ba77817e1650e5b090ff5f6253b916563","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-64093b17b3a9c67a41aa33eb37adb53ec38df714","semester":"1262","observed_at":"2025-05-22 02:11:02.531191+00:00","record_version_id":"861e10dfe45e8fe09303304f04b00b14dd68d3a8a7d67379c73489463deb49fc","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6885b56099f55e08aa0205546369fb0381d50e13","semester":"1262","observed_at":"2025-07-13 04:59:22.367394+00:00","record_version_id":"a26ab0b28ce49664e66b94b7cf67cc23ea6859567a963d00448b8ac3f532fcec","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-69d4b2b16e8268f75b6390b3a0e2ce8bf73999da","semester":"1262","observed_at":"2025-06-30 03:21:29.925498+00:00","record_version_id":"13c307ac45d23b396a5626ad958d9c08f41e3fea2e3ce1d2d69e3d2db8be7243","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-6b29c3e0673b2f9a736d2363db5409e03d5b3ed4","semester":"1264","observed_at":"2025-12-03 12:33:41.418072+00:00","record_version_id":"f1eca091a3223db78fea674785f7421053b10d31f3b3f06eccd7174075f86cb1","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-73259984748de484976ef2ad56ad7ab3d4cb4518","semester":"1262","observed_at":"2025-06-26 08:27:56.461216+00:00","record_version_id":"31487864347353793d4558cbdc0312a4ab1384dfadc33b6460324522c3c25d59","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-741602fbc6252c232a0b9e6bc1a9ae3101625f5a","semester":"1262","observed_at":"2025-06-30 22:49:32.522034+00:00","record_version_id":"c4118ef7872895a43d66d82b02f2ef4acb3293bb1974c20b698c4e047ef76ed9","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7774f45558276ec29bf626e58fffb4a27bdbb2a9","semester":"1264","observed_at":"2025-11-01 11:49:36.359151+00:00","record_version_id":"7dcb8ecf49fc4c788ebd381b1a39222f69c51ca8bac62bad13a82afd333d1011","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ab7c5e783fc8ebef8b8ee8cea019ee37a72ce74","semester":"1262","observed_at":"2025-09-28 04:58:07.340658+00:00","record_version_id":"699db33c3649f349b911c150f5ef2b8f1d5d9afda80b0ec2482a70a955d59b13","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7b2f22d83ea05055ab90dcb77dc802382cccc6f7","semester":"1262","observed_at":"2025-05-21 17:56:46.096741+00:00","record_version_id":"55e75c7ae6606de26e3c14f98de571d577d63beb3689244f5bb4428dc9271d9b","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7ca1175502be18eb51f7b016818a884a43fd4ebb","semester":"1262","observed_at":"2025-07-29 06:28:23.644795+00:00","record_version_id":"37b9461f1ec57dfdceb4c3ec68630ca2489740904d3c3e60a44de07648c8d09f","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-7d8cee5e42602ad9ba5dc0322085af2fa0dffaac","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"97e55d1a818eb775a5815d8936d138b9cc7338102e15b94eb58346ed9f79c53b","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-81a0d6a7f668c98c59bd05fa988aa079c5ad1f68","semester":"1262","observed_at":"2025-05-31 07:49:50.419452+00:00","record_version_id":"4f116337bbd2ad2d7b1606b898cb688f066dc195e45b4dbae993d977f5b5b610","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-82f31c08c746a214872494cde6ecaeb9330441b4","semester":"1262","observed_at":"2025-06-17 21:26:08.547156+00:00","record_version_id":"59a212ecde6d11e0cf4ab8df0ef04cf2fed93675029882c7626ab131d67a4bbc","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-84c248343c5a99ab42c5616c594812a5e3e31cbb","semester":"1262","observed_at":"2025-07-04 06:00:07.487827+00:00","record_version_id":"3a5503f0fe44618a86cbc3c2c3d9e48048c4d664a902eddcf31b164e4d8ed672","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86334e7275e315853287e8580c35456c68df800b","semester":"1262","observed_at":"2025-05-22 06:53:03.336354+00:00","record_version_id":"aabccd7ff7cc9e0cda59a47e9370ecbbac011711babd5e5de21ca89f97560d04","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8686dc1664f93a6c05f50321410961b39b12f91b","semester":"1262","observed_at":"2025-05-28 10:17:41.595894+00:00","record_version_id":"08ad6c058697e0659c137cc6856214583831a6e31931ad96d9e7f743190dfffa","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-86d941366886c9a14a2581c04e20d0bdd25e1b02","semester":"1262","observed_at":"2025-08-31 04:54:14.656039+00:00","record_version_id":"011011d42ae552bccd0b7bddbad89ef716967ff6c36dfa36c3e160ec209f6b02","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-8ba1d2e6cfbb1525b4f9f769ec164fb6ad0f237a","semester":"1262","observed_at":"2025-06-02 05:22:45.010398+00:00","record_version_id":"347be2234f36117dace58e1a326b14dfa861db65f115d20cabebd1833bdfff26","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-90e5aa456689a3b222016c05c319bbcd0bddd453","semester":"1262","observed_at":"2025-05-25 02:00:10.037905+00:00","record_version_id":"a4d79804126f7cc3e80b11a7e4b170429eeb7be9e4a4606b86797866100ee73c","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-92d960aa7e4cd6e4c9ac8b2e232092904038e9e4","semester":"1262","observed_at":"2025-06-08 01:50:46.451351+00:00","record_version_id":"c4f004af11db20228efd1edd99580a4c5ca7a1fd063b1832f56a16dd03a200b9","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-94002ae588a8f71eca6d64105f2e603e8587293b","semester":"1262","observed_at":"2025-05-21 09:01:16.021508+00:00","record_version_id":"ec7ef3d00f799f4e5130f1a5a006aea5e8cacf19bf740fb5a20983cbd5ffa549","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-9dd575e013c5c6e000ab3ad2d1288cc1dd9c96dc","semester":"1264","observed_at":"2025-12-21 04:47:46.589081+00:00","record_version_id":"e78be747846febc742d6f234189c60390648ea48178450e0015f2211f9963ca9","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a1ea26ed78cbd6e94bc3221e50a6ed9b6bf43871","semester":"1262","observed_at":"2025-05-25 09:16:55.180581+00:00","record_version_id":"18bf7c75a991d928c2564245f5445f1f8bb2ebd9bc741a65f6cdb7cd7f24488a","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-a76a3505853d5ea9c13bb98472b87361d469e2ee","semester":"1262","observed_at":"2025-05-28 18:03:41.793846+00:00","record_version_id":"159e7ee495bf7fda05146cbacd7960e5968de10cf00b857d45c79cf39ed166bc","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b285d591f6acf3aa1910e02edc297664db86eb8c","semester":"1262","observed_at":"2025-06-10 22:48:22.460295+00:00","record_version_id":"1a00d2e5a8dd071df65069efca0621a584f947c12ed320afa1b331180088c8b7","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b79af756e4f00ba98231feb859ed8e98239eb811","semester":"1262","observed_at":"2025-05-22 02:47:56.931581+00:00","record_version_id":"f92028e5409df7c5d52b184d454ca86a44ce6a77e4d669dfdbf13fc0d5e02721","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b89e05b94730c6471439082d9279c0a834a4aeec","semester":"1262","observed_at":"2025-08-26 20:25:42.325239+00:00","record_version_id":"bd3de54ea8dd6fae637af7d63e45c4dfa100edc11f957c838e9ee82bd73a3959","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-b9279a12d1f2688df9e556183c94d41a89e431dc","semester":"1262","observed_at":"2025-07-06 01:49:47.203835+00:00","record_version_id":"82a480bf78f161ebb3f761cd916830fbab6580610eaa18fd55ba6da7d8b316f7","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bbdc905e96cc681a5e9a8b02c795b682206e36d1","semester":"1262","observed_at":"2025-06-25 08:02:45.445730+00:00","record_version_id":"07a29792142319d280bf7224eba07cf8cc133a919e76bb49e94b3411691f2039","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-bde225b5243a13d81827aa173e39c78a652b54a0","semester":"1262","observed_at":"2025-05-23 07:22:33.219345+00:00","record_version_id":"96a7d4ac29586f1a46ddfd4dda8602e045479cb6ba35d6e57919d82d71e38bf7","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c1fac4cbfde737f4f4ac02cdf15e6f5a9b5b676d","semester":"1262","observed_at":"2025-05-22 01:15:19.291664+00:00","record_version_id":"97e55d1a818eb775a5815d8936d138b9cc7338102e15b94eb58346ed9f79c53b","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-c6b62be45f8a13cba109ef2a7741b9cd9a6b8272","semester":"1262","observed_at":"2025-08-24 08:48:09.035112+00:00","record_version_id":"94a1e4d03e28843a388e863979af1482cfa907a3625d09da44f79da318fd3f8d","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-cc83f62cb6db61f39320916d819ad48ce55cd96d","semester":"1262","observed_at":"2025-05-22 00:45:35.735230+00:00","record_version_id":"58689648f4333cf3299d7c5162f9f56da6edd19670f9f9075656223a388d15c9","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d33818a01b6b4c5e2902e704da6e5b713742d4dc","semester":"1262","observed_at":"2025-10-13 10:46:24.251475+00:00","record_version_id":"9493a83067af016c453bb252ce58f2b0de10fec6bc0be88d6a483efe5476b0f3","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d3c17db9832d3064916046caf891dd23f10b1bb9","semester":"1262","observed_at":"2025-08-26 11:30:42.288639+00:00","record_version_id":"83324f73b5e52378f22a193ab76e8f0c733c3e0bc31ec980c379c018a41ff5e0","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d4ee226dc44268e9b6767fb9f5f20343322f494b","semester":"1262","observed_at":"2025-06-15 01:52:23.911697+00:00","record_version_id":"092b0580da158f3a2914477a69be0ccb84d14035fbb536aa3fd5bebe257b5c7d","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-d8f9fc7f136e2033556d9d65bbdbdf33425dbdc9","semester":"1262","observed_at":"2025-05-28 16:48:12.400438+00:00","record_version_id":"e9a750770a4f32ebd73b86c35b64b7f028a95363d8090ad19b4a78daf6620801","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbbc9739c616c3846b2e796e00a36fa41225f7d8","semester":"1262","observed_at":"2025-06-01 17:47:19.325144+00:00","record_version_id":"ab915cc68054fc896ee2cfe802def7a6f0b3a0cbe69d9a2aff35f63e93aaec94","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dbe5f2d24b48c3177297a3d69c553cc9d1194bac","semester":"1262","observed_at":"2025-09-14 05:00:27.366070+00:00","record_version_id":"f9dd36e28262b22feebecce7a671cfad63522142b89eb4fbbce4c9cc18df97f3","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-dd357dc2758e9e282c30988a527ce37de92593b9","semester":"1264","observed_at":"2025-10-19 01:39:41.951404+00:00","record_version_id":"3b63c5618248534aa49370db4ee2161a3984df46dce8b2e9c9345c13c30a57dc","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-de74de559e409a3fe668685e28043b888d2e6841","semester":"1262","observed_at":"2025-06-27 07:38:50.882897+00:00","record_version_id":"a90e7fa6c85fc5cd2ff84e52d5efad606b78f66f187ba7e2ace9093f5d74e404","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-deca7188cf536ade3203cd88b52a45e92a059617","semester":"1262","observed_at":"2025-06-27 00:37:46.087071+00:00","record_version_id":"1f7f5fecf5edebae09d76f115e1846df94475ea79d4082623b325b295c834fd2","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-df60fa9ac3931c5612b0fa641b7a6f5fbec86fab","semester":"1262","observed_at":"2025-05-24 06:36:37.554678+00:00","record_version_id":"1a240de08f52d2b3ce6945045b28606043536a6c804403f5fce91c77c3f41b3c","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e339da2d849aaf8bb4dceca07a84728af23cf755","semester":"1262","observed_at":"2025-07-23 08:49:22.748925+00:00","record_version_id":"6bbc85031af1e739bd6fe05b1ddd04af78617137b82db976d92236518ee3e48e","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-e934b1784835f5d36ae9b7ef0992b11e72c39142","semester":"1262","observed_at":"2025-06-01 06:21:25.219533+00:00","record_version_id":"501a704b3e83b6adf27a20a1c704b510da77a92cbd33e4d3e62649a61b740a96","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-ef471690c082448deebd2687eab84b0b78813c36","semester":"1262","observed_at":"2025-06-29 01:47:56.317645+00:00","record_version_id":"371b7212329d0e5d324179f7a7e4a3979ce11de5032d131c7815a286053867c6","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-efc4e8e2cd7c3f68e059a308990c00c77c7611eb","semester":"1264","observed_at":"2025-10-16 05:48:13.935141+00:00","record_version_id":"6ccbf90fffa39c6140c82b2bf570de8e47bdb3272b78a26416449a9902d40c5f","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","course_number":757,"subjects":["PHMSCI"],"title":"INTRODUCTION TO DRUG DEVELOPMENT","description":"Scientific process of drug development from discovery through clinical trials.  Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development.  Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"},{"run_id":"legacy-f18b7749725097d41f69c60779ff38cf073b93b3","semester":"1262","observed_at":"2025-05-21 19:52:03.259353+00:00","record_version_id":"1289ba02eabd3d4628754528e0d09f5bae17c3541aa14839740c6e4f8a766cfb","course_id":"PHMSCI 757","course_uid":"course_d3622f59db7ca8cad98b7104","catalog_version_id":"27b66ce5a34dffea943698efb9f75d00cf29d1edd73e018a08070f33eb2b63f7","course_number":757,"subjects":["PHMSCI"],"title":"SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS","description":"Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.","requirements_text":"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation","official_learning_outcomes_json":"[]"}]